Navigation Links
Pharmos Corporation to Present at the 2007 RBC Capital Markets Healthcare Conference
Date:12/10/2007

Company Selected to Participate in Gastroenterology Panel Discussion

ISELIN, N.J., Dec. 10 /PRNewswire-FirstCall/ -- Pharmos Corporation (Nasdaq: PARS) announced today that Chief Executive Officer Elkan R. Gamzu, Ph.D. will participate in a gastroenterology-focused panel discussion at the 2007 RBC Capital Markets Healthcare Conference taking place December 12 - 13, 2007 at the Westin New York at Times Square in New York, New York. The panel is entitled "Going With Your Gut: New Treatments for GI Disorders," and is scheduled to commence at 8:00 AM Eastern Time on Wednesday, December 12, 2007.

An audio-only webcast and replay of Pharmos' presentation will be available at http://www.wsw.com/webcast/rbc84/panel1 and can be accessed via the Company's website at http://www.pharmoscorp.com.

Pharmos Corporation is a biopharmaceutical company that discovers and develops novel therapeutics to treat a range of diseases of the nervous system, including disorders of the brain-gut axis, with a focus on pain/inflammation and autoimmune disorders. The Company's lead product, dextofisopam, is being studied in a Phase 2b clinical trial in patients with irritable bowel syndrome (IBS). Dextofisopam has completed a Phase 2a IBS study in which it demonstrated a statistically significant effect compared to placebo on the primary efficacy endpoint of adequate relief (n=141, p=0.033) and was very well tolerated. A second clinical program currently in Phase 2a testing is Pharmos' proprietary NanoEmulsion cream drug delivery system formulated with the NSAID diclofenac, which is being studied as a treatm
'/>"/>

SOURCE Pharmos Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Pharmos Issues Letter to Shareholders
2. Pharmos Corporation Reports 2007 Third Quarter Results
3. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
4. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
5. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
6. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
7. BioElectronics Corporation Announces Singapore and Malaysia Sales
8. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
9. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
10. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
11. Luminex Corporation to Present at Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Pittcon is pleased to announce that the ... Horiba Scientific, have organized a session on nanotechnology for ... , Asia’s largest analytical and scientific instruments show, will ... , The four speakers in this U.S. symposium, ... to Single Cells” will present their use of nanotechnology ...
(Date:8/29/2014)... Boston, MA (PRWEB) August 29, 2014 ... ones in the biotech start-up dense realm of Boston-Cambridge, ... alliances and able investors. James Sherley, the Director of ... made increasing the local and national visibility of his ... in September 2013. , In addition to a social ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 “This kit has ... to screen from 0 to 150 ppb,” said Mark Tess, ... a significant benefit to plant owners and USDA-GIPSA inspection agencies ... other commodities. Testing can take place in a matter of ... can the plant test the feed and grain before accepting ...
(Date:8/28/2014)... , Aug. 28, 2014  Next month, executives from ... three key industry events beginning with Patient-Centered Clinical Trials ... in Boston , September 4-5. Patient recruitment ... and Aaron Fleishman will share insights on the ... a variety of tactics – from media to mobile apps ...
Breaking Biology Technology:Fifth Annual U.S. Symposium at JASIS Organized by Pittcon’s Program Chairman Hub MacDonald 2The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 2The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 3The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 4BBK Worldwide Leads Sessions at Key September Events 2
... Also Appoints a New President and Adds A New ... appointed chief executive officer and Maureen Lister was appointed ... during the annual meeting of its Board of Directors. ... Scott, the Institute,s previous president, due to complications from ...
... Pharmaceuticals, Inc., a privately held drug development company, announced ... clinical trial of GGTI-2418. GGTI-2418 is a synthetic ... apoptosis by downregulating several pivotal oncogenic and tumor survival ... O,Dwyer, Professor of Medicine at the University of ...
... Tepha Corporate Partner, Aesculap AG, Introduces MonoMax(R) Monofilament Suture ... following Receipt of CE Mark LEXINGTON, Mass., May ... announced today that its corporate partner, Aesculap AG, has ... monofilament absorbable suture for general surgical indications in Europe. ...
Cached Biology Technology:ALS Therapy Development Institute, the World's Largest Non-Profit Biotech, Appoints Steve Perrin, Ph.D., as Chief Executive Officer 2ALS Therapy Development Institute, the World's Largest Non-Profit Biotech, Appoints Steve Perrin, Ph.D., as Chief Executive Officer 3First Patient Dosed in Phase I Clinical Trial of Tigris Pharmaceuticals' GGTI-2418 2First Patient Dosed in Phase I Clinical Trial of Tigris Pharmaceuticals' GGTI-2418 3Tepha Partner Launches Novel Monofilament Absorbable Suture Utilizing Tepha's Proprietary Biomaterial 2Tepha Partner Launches Novel Monofilament Absorbable Suture Utilizing Tepha's Proprietary Biomaterial 3
(Date:8/28/2014)... for delivering compounds that could positively impact ... may be possible, thanks to researchers in ... semi-soft vaginal suppository made from the seaweed-derived ... antiviral drug Tenofovir provides a woman-initiated, drug-delivery ... of sexually transmitted infections during unprotected heterosexual ...
(Date:8/28/2014)... Philadelphia, PA, August 28, 2014 Dyslexia, the ... States, is a neurological reading disability that occurs ... written language don,t function normally. , The use ... how brain activity is disrupted in dyslexia. However, ... small number of brain regions, leaving a gap ...
(Date:8/28/2014)... first person to alert the world to Global Warming, ... captured and stored underground. He says that Carbon Capture, ... best way to avoid global warming getting out of ... University, New York) made the call during his presentation ... 150 scientists are meeting to discuss Carbon Capture and ...
Breaking Biology News(10 mins):Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 2Sensory-tested drug-delivery vehicle could limit spread of HIV, AIDS 3Dyslexic readers have disrupted network connections in the brain 2Global warming pioneer calls for CO2 to be taken from atmosphere and stored underground 2
... (August 18, 2011) Heart disease has sometimes been considered ... the US alone, more than 42 million women live with ... of deaths among American women each year, making it the ... the signs of heart attack in women differ from those ...
... A common deformity that cases a depression in the ... a national study of 327 patients published in the ... we have observed anecdotally, that children with more severe pectus ... higher degree of exercise intolerance," said one of the study,s ...
... from the Max Planck Institute for Dynamics and ... the speed of synchronisation of complex networks in collaboration ... model using three very different oscillators acting on complex ... oscillators. As a result, for all tested networks they ...
Cached Biology News:October 2011 conference focuses on the role of gender in cardiovascular disease 2October 2011 conference focuses on the role of gender in cardiovascular disease 3October 2011 conference focuses on the role of gender in cardiovascular disease 4
Sf21 Insect Cells (Live) in Max-XP Medium...
Dual-bay Dyad thermal cycler chassis, does not include the Alpha units (requires 2)...
EZ-DeWax is a one-step solution that simultanously removes paraffin from and rehydrates formalin-fixed, paraffin embedded tissue...
Artisan™ Wash Solution (x 50) Additional Information: EU regulatory status: CE US regulatory status: IVD ...
Biology Products: